Search

everythinglearnresearchcommunity

for

Search:↓

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Erdr1 could be a new marker for diagnosing hair loss.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Leflunomide is more likely to help treat alopecia areata than cause it.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Upadacitinib may effectively treat alopecia areata without side effects.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Ajwain seed extract improved skin healing and hair growth in a mouse skin irritation model.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Skin bacteria can help wound healing by activating certain immune cells.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

VEGF helps hair grow and determines follicle size by increasing blood vessel growth.